HLA-HAPLOIDENTICAL HEMATOPOIETIC STEM CELL TRANSPLANTATION ：A VALID ALTERNATIVE OPTION FOR PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA

EHA Library, Feng Chen, 133523

GENE MUTATIONS IN INHERITED BONE MARROW FAILURE SYNDROME REVEALED BY NEXT GENERATION SEQUENCING: COMPARISON WITH CHROMOSOME BREAKAGE TEST

EHA Library, Si Nae Park, 133524

PROSPECTIVE STUDY ON THE USE OF PEGFILGRASTIM IN CHILDREN WITH SEVERE CONGENITAL NEUTROPENIA

EHA Library, Francesca Fioredda, 133525

IKAROS PROTEIN EXPRESSION IN BONE MARROW B AND T CELLS RATHER THAN MYELOMA CELLS PREDICTS OUTCOME AFTER LENALIDOMIDE-DEXAMETHASONE THERAPY

EHA Library, Arnold Bolomsky, 133526

CXCL13 CHEMOKINE – A NOVEL TARGET IN MULTIPLE MYELOMA MICROENVIRONMENT

EHA Library, Katia Beider, 133527

MESENCHYMAL STEM CELLS (MSC) PROMOTES TUMOR MICROENVIRONMENT TRANSFORMATION DRIVING GRANULOCYTE-LIKE MYELOID DERIVED SUPPRESSOR CELLS (G-MDSC) ACTIVATION IN SMOLDERING AND MULTIPLE MYELOMA PATIENTS

EHA Library, Daniele Tibullo, 133528

TARGETING OF BMI-1 WITH PTC-209 AFFECTS MYELOMA CELL GROWTH & SURVIVAL AND IMPAIRS THE TUMOUR MICROENVIRONMENT

EHA Library, Arnold Bolomsky, 133529

LENALIDOMIDE MAINTENANCE COUNTERACTS PD-1 ELEVATION ON LYMPHOCYTES IN MYELOMA PATIENTS

EHA Library, SOPHIA DANHOF, 133530

CIRCULATING SERUM MIRNA PROFILE IN AL AMYLOIDOSIS

EHA Library, Katerina Growkova, 133531

PRECLINICAL EVALUATION OF ABBV-838, A FIRST-IN-CLASS ANTI-CS1 ANTIBODY-DRUG CONJUGATE FOR THE TREATMENT OF MULTIPLE MYELOMA

EHA Library, Kurt Gish, 133532

SOLUBLE BCMA BINDS ITS LIGAND BAFF AND PREVENTS NORMAL ANTIBODY PRODUCTION IN MULTIPLE MYELOMA PATIENTS

EHA Library, James Berenson, 133533

DIFFERENTIAL EFFECTS OF ELOTUZUMAB (ANTI-SLAMF7) AND ANTI-CD38 MONOCLONAL ANTIBODIES IN PRECLINICAL MODELS

EHA Library, Natalie Bezman, 133534

NRF2 ACTIVITY IN BONE MARROW MESENCHYMAL STROMAL CELL PROTECTS MULTIPLE MYELOMA FROM CARFILZOMIB AND BORTEZOMIB INDUCED CELL DEATH

EHA Library, Yu Sun, 133535

PHASE 1B STUDY OF AN ALTERNATIVE LIQUID FORMULATION OF ACY-1215 (RICOLINOSTAT) IN COMBINATION WITH POMALIDOMIDE AND DEXAMETHASONE IN PATIENTS WITH RELAPSED OR RELAPSED-AND-REFRACTORY MULTIPLE MYELOMA

EHA Library, Sumit Madan, 133536

DEVELOPMENT OF A PREDICTIVE MODEL TO IDENTIFY PATIENTS WITH MULTIPLE MYELOMA NOT ELIGIBLE FOR AUTOLOGOUS TRANSPLANT AT RISK FOR SEVERE INFECTIONS USING DATA FROM THE FIRST TRIAL

EHA Library, Charles Dumontet, 133537

OUTCOME OF MYELOMA PATIENTS WITH DELETION 17P – IMPACT OF BASELINE CHARACTERISTICS, TREATMENT AND ADDITIONAL CHROMOSOMAL CHANGES

EHA Library, Maximilian Merz, 133538

CIRCULATING TUMOR DNA IN MULTIPLE MYELOMA

EHA Library, Even Rustad, 133539

SINGLE-AGENT IBRUTINIB IN RITUXIMAB-REFRACTORY PATIENTS WITH WALDENSTRÖM’S MACROGLOBULINEMIA (WM): UPDATED RESULTS FROM A MULTICENTER, OPEN-LABEL PHASE 3 SUBSTUDY (INNOVATETM)

EHA Library, Meletios Dimopoulos, 133540

POMALIDOMIDE, BORTEZOMIB, AND LOW-DOSE DEXAMETHASONE IN PROTEASOME INHIBITOR–EXPOSED AND LENALIDOMIDE-REFRACTORY MYELOMA: RESULTS OF A MULTICENTER, DOSE-ESCALATION, PHASE 1 TRIAL (MM-005)

EHA Library, PAUL RICHARDSON, 133541

PROSPECTIVE COMORBIDITY AND FUNCTIONAL GERIATRIC ASSESSMENT (CF-GA) IN MULTIPLE MYELOMA (MM) PATIENTS (PTS): RESULTS FROM A MULTICENTER GERMAN STUDY GROUP MM (DSMM) TRIAL

EHA Library, Sandra Dold, 133542

IMPACT OF CYTOGENETIC RISK ON PFS2 OF PATIENTS TREATED WITH DIFFERENT THERAPY SEQUENCES: RESULTS OF A POST-HOC ANALYSIS

EHA Library, Massimo Offidani, 133543

A FRAILTY SCALE PREDICTS OUTCOMES IN TRANSPLANT-INELIGIBLE PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA TREATED WITH CONTINUOUS LENALIDOMIDE PLUS LOW-DOSE DEXAMETHASONE IN THE FIRST (MM-020) TRIAL

EHA Library, Thierry Facon, 133544

PROSPECTIVE EVALUATION OF GERIATRIC ASSESSMENT TOOLS IN REAL-WORLD, UNSELECTED, ELDERLY PATIENTS WITH SYMPTOMATIC MYELOMA

EHA Library, Efstathios Kastritis, 133545

IS THERE A PROGNOSTIC IMPACT OF THE CEREBLON EXPRESSION IN MULTIPLE MYELOMA?

EHA Library, Jelena Bila, 133546

CARFILZOMIB AND DEXAMETHASONE VS SUBCUTANEOUS BORTEZOMIB AND DEXAMETHASONE IN PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA: SECONDARY ANALYSIS FROM THE PHASE 3 STUDY ENDEAVOR (NCT01568866)

EHA Library, Hartmut Goldschmidt, 133547

PATIENT-REPORTED QUALITY OF LIFE WITH IXAZOMIB-LENALIDOMIDE-DEXAMETHASONE (IRD) VS PLACEBO-RD IN RELAPSED/REFRACTORY MULTIPLE MYELOMA PATIENTS IN THE GLOBAL, PLACEBO-CONTROLLED TOURMALINE-MM1 STUDY

EHA Library, Xavier Leleu, 133548

WEEKLY CARFILZOMIB WITH DEXAMETHASONE FOR PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA: UPDATED RESULTS FROM THE PHASE 1/2 STUDY CHAMPION-1 (NCT01677858)

EHA Library, James Berenson, 133549

DO MULTIPLE MYELOMA R/R PATIENTS BENEFIT FROM EARLY TREATMENT AT BIOLOGICAL RELAPSE? PRELIMINARY RESULTS OF A SPANISH OBSERVATIONAL PROSPECTIVE REGISTRY

EHA Library, Carlos Fernandez Delarrea, 133550

EFFICACY AND SAFETY BY CYTOGENETIC RISK STATUS: PHASE 3 STUDY (ASPIRE) OF CARFILZOMIB, LENALIDOMIDE AND DEXAMETHASONE VERSUS LENALIDOMIDE AND DEXAMETHASONE IN PATIENTS WITH RELAPSED MULTIPLE MYELOMA

EHA Library, Hervé Avet-Loiseau, 133551

A SUBSTUDY OF THE PHASE 3 ENDEAVOR STUDY: SERIAL ECHOCARDIOGRAPHIC ASSESSMENT OF PATIENTS WITH RELAPSED MULTIPLE MYELOMA (RMM) RECEIVING CARFILZOMIB PLUS DEXAMETHASONE OR BORTEZOMIB PLUS DEXAMETHASONE

EHA Library, ROMAN HAJEK, 133552

PROGNOSTIC FACTORS IN PATIENTS WITH MULTIPLE MYELOMA AND STANDARD-RISK CYTOGENETICS

EHA Library, Moritz Binder, 133553

CLINICAL CHARACTERISTICS AND LONG-TERM OUTCOME ON IMATINIB IN PATIENTS WITH MYELOID/LYMPHOID NEOPLASMS AND ASSOCIATED PDGFRB FUSION GENES IN CHRONIC OR BLAST PHASE

EHA Library, Georgia Metzgeroth, 133554

THROMBOTIC RISK IN IDIOPATHIC ERYTHROCYTOSIS IS LOWER THAN IN POLYCYTHEMIA VERA BUT HIGHER THAN IN GENERAL POPULATION.

EHA Library, Maria Luigia Randi, 133555

AZACITIDINE IN THE TREATMENT OF PH- MYELOPROLIFERATIVE NEOPLASMS IN BLASTIC PHASE: THE EXPERIENCE OF GRUPPO LAZIALE FOR THE STUDY OF PH- SMPC

EHA Library, Ambra Di Veroli, 133556

COMPARISON OF GENOMIC DNA-BASED VS. MESSENGER RNA-BASED KIT D816V MUTATION ANALYSIS REVEALS LARGE DIFFERENCES BETWEEN BLOOD AND BONE MARROW IN SYSTEMIC MASTOCYTOSIS

EHA Library, Thomas Kristensen, 133557

3167 NEWLY DIAGNOSED MPN PATIENTS, A REPORT FROM THE SWEDISH MPN REGISTRY

EHA Library, Björn Andréasson, 133558

PREDICTIVE ROLE OF CIRCULATING LEUCOCYTE-PLATELET AGGREGATES FOR THROMBOEMBOLIC COMPLICATIONS IN PHILADELPHIA-NEGATIVE MYELOPROLIFERATIVE NEOPLASMS: A PROSPECTIVE STUDY

EHA Library, Dijana Sefer, 133559

PREDICTORS FOR RESPONSE TO RUXOLITINIB IN REAL-LIFE: AN OBSERVATIONAL INDEPENDENT STUDY ON 266 PATIENTS WITH MYELOFIBROSIS

EHA Library, Nicola Polverelli, 133560

MYELOPROLIFERATIVE NEOPLASIA ASSOCIATED WITH SPLANCHNIC VEIN THROMBOSIS IS CORRELATED WITH DISTINCT CLINICAL FEATURES AND LOW JAK2 V617F ALLELE BURDEN.

EHA Library, Wanda Toscano, 133561

BONE MARROW MICROVESSEL DENSITY AND PLASMA ANGIOGENIC FACTORS IN BCR-ABL1 NEGATIVE MYELOPROLIFERATIVE NEOPLASMS: A STUDY OF 90 PATIENTS WITH CLINICOPATHOLOGICAL AND MOLECULAR CORRELATIONS

EHA Library, Danijela Lekovic, 133562

ANAGRELIDE CONTROLLED RELEASE (GALE-401) SAFETY PROFILE CONSISTENTLY WELL TOLERATED IN MYELOPROLIFERATIVE NEOPLASMS PATIENTS AND HEALTHY VOLUNTEERS

EHA Library, Srdan Verstovsek, 133563

PROGNOSTIC IMPACT OF INTEGRATED GENOMIC PROFILING IN ADULT T-CELL LEUKEMIA/LYMPHOMA

EHA Library, Keisuke Kataoka, 133564

HNRNP K: A NOVEL ONCOGENE THAT DRIVES C-MYC-DEPENDENT LYMPHOMAS AS A POTENTIAL THERAPY TARGET

EHA Library, Miguel Gallardo, 133565

GENOMIC PROFILING REVEALS SPATIAL HETEROGENEITY IN FOLLICULAR LYMPHOMA: IMPLICATIONS FOR PRECISION MEDICINE.

EHA Library, Shamzah Araf, 133566

SOMATIC MUTATION PROFILING FOR PROGNOSIS AND TREATMENT STRATIFICATION OF DIFFUSE LARGE B-CELL LYMPHOMA IN THE REMODL-B TRIAL

EHA Library, Ming Qing Du, 133567

ADHESION MOLECULE JAM-C: A POTENTIAL TARGET FOR MANTLE CELL LYMPHOMA THERAPEUTICS

EHA Library, Thomas Matthes, 133568

ATM GENE MUTATIONS REPRESENT A HALLMARK OF MANTLE CELL LYMPHOMA BUT DO NOT IMPACT PATIENTS´ SURVIVAL

EHA Library, Andrea Marečková, 133569

MODE OF ACTION OF DIFFERENT PI3K-INHIBITORS IN MANTLE CELL LYMPHOMA

EHA Library, Grit Hutter, 133570

TP53 AND KMT2D MUTATIONS PREDICT PFS IN MCL PATIENTS TREATED WITH HIGH-DOSE THERAPY AND AUTOLOGOUS TRANSPLANTATION: RESULTS FROM THE MCL0208 PHASE III TRIAL FROM FONDAZIONE ITALIANA LINFOMI (FIL)

EHA Library, Simone Ferrero, 133571

DECIPHERING THE IMPACT OF IDELALISIB ON FOLLICULAR LYMPHOMA AND ITS IMMUNE MICROENVIRONMENT

EHA Library, Alba Matas-Céspedes, 133572

MIR-34A PREVENTS LUNG INJURY IN BLEOMYCIN INDUCED PULMONARY FIBROSIS

EHA Library, Raanan Bulvik, 133573

INTERIM ANALYSIS OF POST MARKETING SURVEILLANCE OF YTTRIUM-90　IBRITUMOMAB TIUXETAN IN JAPANESE PATIENTS WITH RELAPSED OR REFRACTORY INDOLENT B-CELL NON-HODGKIN LYMPHOMA OR MANTLE CELL LYMPHOMA

EHA Library, Kiyohiko Hatake, 133574

PATIENTS WITH FOLLICULAR LYMPHOMA (FL) SHOWING A DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL) COMPONENT HAVE AN INTERMEDIATE OUTCOME BETWEEN FL AND DLBCL

EHA Library, Laura Magnano, 133575

DISTINCT INCREASING TREND AND BIRTH-COHORT EFFECT OF FOLLICULAR LYMPHOMA INCIDENCE IN TAIWAN: EPIDEMIOLOGICAL ANALYSES AND IMPLICATIONS

EHA Library, Wu Shang Ju, 133576

LONG-TERM OUTCOMES OF 131I-RITUXIMAB RADIOIMMUNOTHERAPY IN FOLLICULAR NON-HODGKIN LYMPHOMA: TEN YEAR UPDATE ON TOXICITY, TIME-TO-NEXT-TREATMENT AND SURVIVIAL OF THE PHASE II INITIAL STUDY

EHA Library, Murali Kesavan, 133577

LONG TERM OUTCOMES IN PRIMARY OCULAR ADNEXAL MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMAS (POAML): A LARGE SINGLE INSTITUTE COHORT STUDY.

EHA Library, Amrita Desai, 133578

EARLY TRANSFORMATION IN LOW-GRADE LYMPHOMAS AND ITS ADVERSE PROGNOSTIC SIGNIFICANCE ON SURVIVAL

EHA Library, Luis Miguel Juárez-Salcedo, 133579

OFATUMOMAB FOR THE TREATMENT OF EXTRANODAL MARGINAL ZONE B-CELL LYMPHOMA OF THE MUCOSA-ASSOCIATED LYMPHOID TISSUE (MALT LYMPHOMA): THE O-MA1 STUDY

EHA Library, Barbara Kiesewetter, 133580

BENDAMUSTINE PLUS RITUXIMAB VERSUS R-CHOP AS FIRST-LINE TREATMENT FOR PATIENTS WITH INDOLENT NON-HODGKIN’S LYMPHOMA: EVIDENCE FROM A MULTICENTER, RETROSPECTIVE STUDY.

EHA Library, Patrizia Mondello, 133581

FINAL RESULTS OF IHC ANALYSIS AND PROGNOSTIC FACTORS IN POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDERS AFTER SOLID ORGAN TRANSPLANTATION

EHA Library, Manali Kamdar, 133582

IMPROVED OUTCOMES WITH HIGH DOSE CHEMOTHERAPY AND AUTOLOGOUS STEM CELL TRANSPLANT IN PATIENTS WITH PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA WITH PRESERVATION OF COGNITIVE FUNCTION

EHA Library, Shireen Kassam, 133583

LENALIDOMIDE IN RELAPSED OR REFRACTORY DIFFUSE LARGE B CELL LYMPHOMA: IS IT A VALID TREATMENT OPTION?

EHA Library, Patrizia Mondello, 133584

NONPEGHYLATED LIPOSOMAL DOXORUBICIN AS A COMPONENT OF R-CHOP IS EFFECTIVE AND SAFE IN THE TREATMENT OF A CARDIAC HIGH-RISK AND ELDERLY LYMPHOMA PATIENTS

EHA Library, Luigi Rigacci, 133585

METHYLATION OF CELL-FREE CIRCULATING DNA IN PLASMA PREDICTS POOR OUTCOME IN DIFFUSE LARGE B-CELL LYMPHOMA

EHA Library, Lasse Sommer Kristensen, 133586

REAL-WORLD EXPERIENCE OF IBRUTINIB IN >700 PATIENTS WITH MANTLE-CELL LYMPHOMA: DATA FROM A GLOBAL NAMED PATIENT PROGRAM

EHA Library, Simon Rule, 133587

A SPECIFIC SIGNATURE IN LYMPH NODE BIOPSIES OF PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL) PREDICTS CENTRAL NERVOUS SYSTEM (CNS) INVOLVEMENT

EHA Library, Ivan Dlouhy, 133588

DIFFUSE LARGE B-CELL LYMPHOMA IN THE RITUXIMAB ERA: REAL LIFE ANALYSIS OF PATIENTS WITH REFRACTORY DISEASE OR RELAPSE

EHA Library, Bente Arboe, 133589

CENTRAL NERVOUS SYSTEM INTERNATIONAL PROGNOSTIC INDEX IN DIFFUSE LARGE B-CELL LYMPHOMA

EHA Library, Naoto Tomita, 133590

BETTER PROGNOSTICATIONS WITH INTERIM PET/CT RESPONSES BASED ON METABOLIC TUMOR VOLUME COMPARED TO VISUAL AND SUV-BASED ASSESSMENTS IN THE PATIENTS WITH DLBCL WITH EXTRANODAL INVOLVEMENTS.

EHA Library, Joon Ho MOON, 133591

DETECTION OF BONE MARROW INVOLVEMENT OF DLBCL - COMPARISON OF PET-CT AND BONE MARROW BIOPSY

EHA Library, Yuki Nakajima, 133592

EFFICACY OF BONE MARROW DERIVED MSC FOR STEROID REFRACTORY ACUTE GVHD IS RELATED TO THE AGE OF THE MSC DONOR

EHA Library, Lotte van der Wagen, 133593

CHRONIC GRAFT-VERSUS-HOST-DISEASE AND B-CELL RECONSTITUTION AFTER HEMATOPOIETIC STEM CELL TRANSPLANTATION IN CHILDREN

EHA Library, Verena Wiegering, 133594

A NOVEL QUANTITATIVE PCR APPROACH TARGETING INSERTION/DELETION POLYMORPHISMS (INDEL-PCR) FOR CHIMERISM QUANTIFICATION: FINALLY HIGH SENSITIVITY AND QUANTIFICATION CAPACITY TOGETHER

EHA Library, Almudena Navarro-Bailón, 133595

A NEW APPROACH OF DUAL-SCT WITH UNMANIPULATED HAPLO-IDENTICAL GRAFT AND UNRELATED CORD BLOOD IN PATIENTS WITH HEMATOLOGICAL DISORDERS

EHA Library, Jia Chen, 133596

RECIPIENT CCR5 GENETIC VARIATION PREDICTS TRANSPLANT OUTCOMES AFTER HLA-MATCHED UNRELATED DONOR BONE MARROW TRANSPLANTATION.

EHA Library, Tomohiro Horio, 133597

PRESUMABLY FALSE POSITIVE MINIMAL RESIDUAL DISEASE (MRD) QPCR RESULTS AFTER ALLOGENEIC SCT UNCOVERED BY NEXT GENERATION SEQUENCING (NGS)

EHA Library, Michaela Kotrová, 133598

PRE-EMPTIVE THERAPY WITH IFN-Α-2B FOR ACUTE LEUKEMIA PATIENTS WITH HIGH RISK OF RELAPSING TENDENCY POST ALLO-HSCT

EHA Library, Xiaowen Tang, 133599

A STUDY OF RHTPO IN COMBINATION WITH CHEMOTHERAPY AND G-CSF FOR PERIPHERAL BLOOD PROGENITOR CELL MOBILIZATION IN PATIENTS WITH RELAPSED NON-HODGKIN LYMPHOMA

EHA Library, Haitao Bai, 133600

A POLYCLONAL POPULATION OF PIGA MUTANT CD52 AND GPI-ANCHOR NEGATIVE T-CELLS CAN GIVE EARLY IMMUNE PROTECTION AFTER ALEMTUZUMAB-BASED T-CELL DEPLETED ALLOGENEIC STEM CELL TRANSPLANTATION

EHA Library, Inge Jedema, 133601

WHICH CONDITIONING REGIMEN IS MORE EFFECTIVE FOR HIGH-RISK PATIENTS WITH AML/MDS : COMPARING LOW-DOSE DECITABINE COMBINED WITH MODIFIED BUCY WITH MODIFIED BUCY FOLLOWED BY ALLO-HSCT

EHA Library, Xiaowen Tang, 133602

ELEVATED EXPRESSION OF TIM-3 ON CD8 T CELLS CORRELATES WITH CYTOMEGALOVIRUS REACTIVATION AFTER ALLOGENIC STEM CELL TRANSPLANTATION

EHA Library, Depei Wu, 133603

INTERFERON-GAMMA GENE POLYMORPHISM ASSOCIATE WITH MORTALITY AND GRAFT-VERSUS-HOST DISEASE SEVERITY IN HLA-MATCHED SIBLING BONE MARROW TRANSPLANTATION

EHA Library, Mariano Berro, 133604

BASELINE LABORATORY VARIABLES SERVE AS POTENT PREDICTORS OF ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION RELATED MORTALITY

EHA Library, Roni Shouval, 133606

CYTOMEGALOVIRUS INDUCES STRONG ANTILEUKEMIC EFFECT IN ACUTE MYELOID LEUKEMIA PATIENTS FOLLOWING SIBLING HSCT WITHOUT ATG-CONTAINING REGIMEN

EHA Library, Huiying Qiu, 133607

COMPARING TIME-DEPENDENT PREDICTIVE PERFORMANCE OF ALLOGENEIC HSCT RISK SCORING SYSTEMS

EHA Library, Joshua Fein, 133608

PROPHYLACTIC DLI VS NO DLI FOR REFRACTORY ACUTE LEUKEMIA UNDERGOING ALLO-HSCT WITH SEQUENTIAL INTENSIFIED CONDITIONING

EHA Library, Qifa Liu, 133609

THE PRE-TRANSPLANT BIOMARKER RISK INDEX BASED ON SERUM FERRITIN, ALBUMIN AND CRP CAN PREDICT OUTCOMES INDEPENDENTLY OF THE HCT-CI AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION

EHA Library, Tatsuya Suwabe, 133610

HAPLOIDENTICAL TRANSPLANTATION FOR PEDIATRIC PATIENTS WITH ACQUIRED SEVERE APLASTIC ANEMIA

EHA Library, Lanping Xu, 133611

COMPARISON BETWEEN FLUDARABINE PLUS BUSULFAN AND FLUDARABINE PLUS MELPHALAN CONDITIONING REGIMENS BEFORE SINGLE-UNIT CORD BLOOD TRANSPLANTATION FOR ADULT ACUTE MYELOID LEUKEMIA PATIENTS

EHA Library, Jun Aoki, 133612

MINIMAL RESIDUAL DISEASE AND GRAFT-VERSUS-HOST DISEASE GUIDED SEQUENTIAL CHEMOTHERAPY PLUS DONOR LYMPHOCYTE INFUSION COULD IMPROVE SURVIVAL OF PATIENTS WITH ACUTE LEUKEMIA WHO RELAPSED AFTER ALLO-HSCT

EHA Library, Chen Hua Yan, 133613

TERMINAL NK CELL MATURATION IS CONTROLLED BY CONCERTED ACTIONS OF T-BET AND ZEB2

EHA Library, Steven Goossens, 133614

BIFURCATION INTO HEMATOPOIETIC STEM CELL TYPES IS DEPENDENTUPON THE DEVELOPMENTAL SIGNALING MOLECULES

EHA Library, Mihaela Crisan, 133615

LACK OF MIR-127 DOWN-REGULATION IN THE TRANSITION FROM HEMATOPOIETIC STEM CELLS TO MULTI-POTENT PROGENITORS LEADS TO PANCYTOPENIA AND DEFECTIVE SELF-RENEWAL

EHA Library, Francesca Ficara, 133616

NAMPT-NAD+-SIRT2 PATHWAY-TRIGGERED DEACETYLATION OF LMO2 PROTEIN IS INDISPENSABLE IN THE EARLY HEMATOPOIESIS THROUGH COMPLETE TAL1 COMPLEX FORMATION

EHA Library, Tatsuya Morishima, 133617

B LYMPHOPOIESIS IS DEPENDENT ON TRANSCRIPTION FACTOR ERG

EHA Library, Elisabeth Søndergaard, 133618

EXPRESSION OF BCL2, BUT NOT STAT5 SIGNALING, RESCUES LYMPHOPOIESIS IN THE ABSENCE OF HHEX

EHA Library, Jacob T Jackson, 133619

ANAMORSIN IS ESSENTIAL FOR B-CELL TERMINAL DIFFERENTIATION

EHA Library, Yuri Hamanaka, 133620

DOWNREGULATION OF CD44 FUNCTIONALLY DEFINES HUMAN T-CELL COMMITMENT

EHA Library, Kirsten Canté-Barrett, 133621

KNOCKDOWN OF THE ADHESION G-PROTEIN COUPLED RECEPTOR 56 IMPAIRS HUMAN CORD BLOOD STEM AND PROGENITOR CELL FUNCTION

EHA Library, Lixiazi He, 133622

DISSECTING THE ROLE OF THE MICROENVIRONMENT IN APLASTIC ANEMIA USING AN IN VIVO HAEMATOPOIETIC STEM CELL NICHE MODEL

EHA Library, Ilaria Marina Michelozzi, 133623